Hint mode is switched on Switch off

Larimar Therapeutics, ordinary share
US5171251003, LRMR

Add a stock to WL
Choose all Reset all
Larimar Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Issuer

Profile
Larimar Therapeutics Inc operates as a biotech company. The Company develops and discovers treatments for complex rare diseases such as protein replacement therapy. Larimar Therapeutics serves customers in the State of Pennsylvania.
  • Issuer
  • Full borrower / issuer name
    Larimar Therapeutics Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    LRMR
  • Placement
    14.09.2022
  • Lock up period
    180
  • Number of papers
    22,225,000
  • Volume of raised funds
    70.01 mln USD
  • Placement share
    55.65%
  • Final placement price
    3.15 USD
  • Price change since placement date
    137.14%
  • By capitalization
    125.8 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    LRMR
  • Placement
    14.02.2024
  • Lock up period
    180
  • Number of papers
    61,068,375
  • Volume of raised funds
    150 mln USD
  • Placement share
    28.1%
  • Final placement price
    8.74 USD
  • Price change since placement date
    -14.53%
  • By capitalization
    533.74 mln USD

IFRS/US GAAP reports

2024
I q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide
Authorization required
You need to request access

Related Stock indices

Indicators

News

09/05/2024 Larimar Therapeutics: Results Of Operations And Financial Condition, Other Events, Financial Statements And Exhibits
11/03/2024 Larimar Therapeutics: Other Events, Financial Statements And Exhibits
13/02/2024 Larimar Therapeutics: Termination Of A Material Definitive Agreement
12/02/2024 Larimar Therapeutics: Results Of Operations And Financial Condition, Other Events, Financial Statements And Exhibits
14/11/2023 Larimar Therapeutics: Results Of Operations And Financial Condition, Other Events, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.